S
Shôn Lewis
Publications - 7
Citations - 17
Shôn Lewis is an academic researcher. The author has contributed to research in topics: Medicine & Mental health. The author has an hindex of 3, co-authored 7 publications receiving 17 citations.
Papers
More filters
Journal ArticleDOI
The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia.
Andrew Gumley,Simon Bradstreet,John Ainsworth,Stephanie Allan,Mario Alvarez-Jimenez,Lorna Aucott,Max Birchwood,Andrew Briggs,Sandra Bucci,Sue M. Cotton,Lidia Engel,Paul French,Reeva Lederman,Shôn Lewis,Matthew Machin,Graeme MacLennan,Hamish J. McLeod,Nicola McMeekin,Cathrine Mihalopoulos,Emma Morton,John Norrie,Matthias Schwannauer,Swaran P. Singh,Suresh Sundram,A. S. Thompson,Chris J. Williams,Alison R. Yung,John Farhall,John Gleeson +28 more
TL;DR: In this article , the authors compared early warning signs monitoring by service users with schizophrenia with treatment as usual in community mental health services (CMHS) in Glasgow and Melbourne, aiming to establish the feasibility of undertaking a definitive randomised controlled trial to determine the effectiveness of a blended digital intervention for relapse prevention in schizophrenia.
Journal ArticleDOI
Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration
Alice Egerton,Kira Griffiths,Cecila Casetta,Bill Deakin,Richard J. Drake,Oliver D. Howes,L Kassoumeri,Sobia Khan,Steve Lankshear,Jane Lees,Shôn Lewis,Elena Mikulskaya,Edward Millgate,Ebenezer Oloyede,Rebecca Janet Pollard,Nathalie Rich,Aviv Segev,Kyra-Verena Sendt,James H. MacCabe +18 more
TL;DR: Using proton magnetic resonance spectroscopy (1 H-MRS), this article examined the ability of glutamate and Glx (glutamate plus glutamine) in the anterior cingulate cortex (ACC) and caudate to predict response to antipsychotic treatment.
Journal ArticleDOI
Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT.
Andrew Gumley,Simon Bradstreet,John Ainsworth,Stephanie Allan,Mario Alvarez-Jimenez,Max Birchwood,Andrew Briggs,Sandra Bucci,S Cotton,Lidia Engel,Paul French,Reeva Lederman,Shôn Lewis,Matthew Machin,Graeme MacLennan,Hamish J. McLeod,Nicola McMeekin,Cathrine Mihalopoulos,Emma Morton,John Norrie,Frank K. Reilly,Matthias Schwannauer,Swaran P. Singh,Suresh Sundram,A. S. Thompson,Chris J. Williams,Alison R. Yung,Lorna Aucott,John Farhall,John Gleeson +29 more
TL;DR: A trial of digital technology to monitor early warning signs that blended with peer support and clinical triage to detect and prevent relapse is feasible and should be considered cost-effective when using the National Institute for Health and Care Excellence threshold.
Journal ArticleDOI
Mental health professionals views and the impact of COVID-19 pandemic on implementing digital mental health in China: A nationwide survey study
TL;DR: Wang et al. as discussed by the authors investigate staff attitudes towards digital technology for mental health problems in China, explore staff's views on the facilitators and barriers regarding uptake and adoption of digital technology in mental health services in China; and understand how the COVID-19 pandemic has changed staff views on digital mental health.
Journal ArticleDOI
Digital screening for postnatal depression: mixed methods proof-of-concept study
TL;DR: ClinTouch DAWN-P as discussed by the authors is a smartphone app that allows parents to monitor their mood daily with the Edinburgh Postnatal Depression Scale (EPDS), uploading responses in real-time to a secure server.